Showing results (371-380 of 722) with videos related to

Sort By:
Pageof 73
The Lancet. Haematology|July 5, 2016
Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trialRichard Greil, Petra Obrtlíková, Lukáš Smolej, et al.
The Lancet. Haematology|April 1, 2016
Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studiesJudith Trotman, Stefano Luminari, Sami Boussetta, et al.
The Lancet. Haematology|April 1, 2016
Early renal damage in patients with sickle cell disease in sub-Saharan Africa: a multinational, prospective, cross-sectional studyBrigitte Ranque, Aymeric Menet, Ibrahima Bara Diop, et al.
The Lancet. Haematology|April 12, 2016
Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 studySandy Amorim, Anastasios Stathis, Mary Gleeson, et al.
The Lancet. Haematology|June 7, 2016
Effect of compression stockings on post thrombotic syndrome in patients with deep vein thrombosis: a meta-analysis of randomised controlled trialsRajeeve Subbiah, Vikas Aggarwal, Huaqing Zhao, et al.
The Lancet. Haematology|July 23, 2017
EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysisThomas Luft, Axel Benner, Sonata Jodele, et al.
The Lancet. Haematology|September 19, 2017
Outcomes of restrictive versus liberal transfusion strategies in older adults from nine randomised controlled trials: a systematic review and meta-analysisGeoff I Simon, Alison Craswell, Ogilvie Thom, et al.
The Lancet. Haematology|May 3, 2016
Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE studyGary Raskob, Walter Ageno, Alexander T Cohen, et al.
The Lancet. Haematology|May 3, 2016
Red blood cell processing methods and in-hospital mortality: a transfusion registry cohort studyNancy M Heddle, Donald M Arnold, Jason P Acker, et al.
The Lancet. Haematology|August 18, 2019
Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studiesPaul Monagle, Anthonie W A Lensing, Kirstin Thelen, et al.
Pageof 73